The biomedical modeling and simulation company Metrum Research Group (MetrumRG) has promoted Michelle Johnson to be its CEO, succeeding founder Marc Gastonguay.
Johnson had served as the chief operating officer of the Ariffville, Connecticut–based company, where she helped assemble the company’s business team. In her new role as CEO, Johnson looks forward to assisting clients in furthering drug development programs with strategic decision-making services. “I am a big believer in the importance of mission and vision,” Johnson said in a recent interview.
Before starting her tenure at MetrumRG, Johnson said she wanted to grow with a company with “endless potential” and where she could “play a part in executing a vision that had a lasting impact on people’s lives.”
“Shortly after I began working at MetrumRG in 2015, I knew this was the place for me,” Johnson said. “I was immediately in awe of …